Here are five things to know:
1. The $4.6 million equity will go toward the company’s working capital.
2. Twenty-three investors participated in the equity round.
3. TrackX is currently developing a medical device intended to decrease radiation exposure during surgeries, as reported by WRAL TechWire.
4. TrackX listed Robert Isaacs, MD, a Durham-based Duke Health neurosurgeon, as a company director and promoter on its recent Securities and Exchange Commission filing.
5. Dr. Isaacs completed his endoscopic and complex spine surgery fellowship at Rush University, Chicago Institute of Neurosurgery and Neuroresearch.
More articles on devices:
Medtronic, Exactech, RTI Surgical & more: 9 device company key notes
AxioMed president comments on outpatient cervical disc replacement study: 5 observations
North America leads global neurosurgery market — 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
